Hypatia Launches Bento Biology Trust Technology for Decentralized Clinical Trials

Written By Alex Nguyen

Hypatia, an engineering firm with distinguished history building AI software factories and consortium blockchains for governments and the Fortune 500, is launching Bento Bio, a clinical trial platform technology that addresses the need for more remote clinical trials and increased patient retention and allows patients to take ownership of and monetize their own data.

Read the full press release here.

Alex Nguyen
Previous

Hypatia Wins Another Three-Year Data Innovation Partnership with U.S. Department of Commerce
Next

Bento Bio: From Data Donorship to Data Ownership - Part 1: The Vision